Tazomeline (LY-287041) is a drug which acts as a non-selective muscarinic acetylcholine receptor agonist. It was in clinical trials for the treatment of cognitive dysfunction such as that seen in Alzheimer’s disease and schizophrenia but development was apparently scrapped for unknown reasons.
This page contains content from the copyrighted Wikipedia article "Tazomeline"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
